Intravenous Recombinant Tissue Plasminogen Activator Administered at Three to Six Hours Following Onset of Ischemic Stroke Does Not Improve Outcome. A Meta-Analysis

被引：0
|
作者：
Maiser, Samuel J.
Suri, M. Fareed K.
Georgiadis, Alexandros
Vazquez, Gabriela
Qureshi, Adnan
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A355 / A355
页数：1
相关论文
共 50 条
  • [31] Dual antiplatelet therapy versus intravenous tissue plasminogen activator with acute minor ischemic stroke: A systematic review and meta-analysis of safety and efficacy
    Abbas, Abdallah
    Hamad, Abdullah Ashraf
    Moawad, Mostafa Hossam El Din
    Ewis, Dalia Kamal
    Youssef, Rana Ahmed
    Hamouda, Heba
    Hassan, Malak A.
    Aladawi, Mohammad
    Elfil, Mohamed
    Meshref, Mostafa
    Al -Mufti, Fawaz
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2024, 33 (07):
  • [32] Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke - Where do we go from here? A cumulative meta-analysis
    Wardlaw, JM
    Sandercock, PAG
    Berge, E
    [J]. STROKE, 2003, 34 (06) : 1437 - 1442
  • [33] Comparing the Effectiveness of Intravenous Tissue Plasminogen Activator and Dual Antiplatelet Therapy in Patients With Minor Stroke: A Meta-Analysis
    Monday, Obinna
    Rawat, Anurag
    Isaak, Abraham K.
    Manzoor, Amima
    Jaiswal, Goldi
    Saeed, Leena
    Kumari, Ajanta
    Amin, Adil
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [34] Clinical safety and outcome of recombinant tissue plasminogen activator in patients with stroke attributable to small artery occlusion A protocol for systematic review and meta-analysis
    Ni, Li-Yan
    Tang, Ji-You
    [J]. MEDICINE, 2021, 100 (25) : E26453
  • [35] PREHOSPITAL STROKE MEDICAL ACTIVATION: IMPACT ON TIMES RESPONSE AND OUTCOME IN PATIENTS WITH ISCHEMIC STROKE TREATED WITH INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR. PRELIMINARY DATA
    Bacelar, N.
    Martinez, M.
    Canovas, D.
    Carvajal, A.
    [J]. INTENSIVE CARE MEDICINE, 2009, 35 : 138 - 138
  • [36] Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous recombinant tissue plasminogen activator: a systematic review and meta-analysis
    Guo, Yijia
    Yang, Yaqiong
    Zhou, Muke
    He, Li
    [J]. STROKE AND VASCULAR NEUROLOGY, 2018, 3 (04) : 203 - 208
  • [37] Risk Factors for Intracranial Hemorrhage in Acute Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator A Systematic Review and Meta-Analysis of 55 Studies
    Whiteley, William N.
    Slot, Karsten Bruins
    Fernandes, Peter
    Sandercock, Peter
    Wardlaw, Joanna
    [J]. STROKE, 2012, 43 (11) : 2904 - U235
  • [38] Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial
    Clark, WM
    Wissman, S
    Albers, GW
    Jhamandas, JH
    Madden, KP
    Hamilton, S
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2019 - 2026
  • [39] Meta-analysis of Vascular Imaging Features to Predict Outcome Following Intravenous rtPA for Acute Ischemic Stroke
    Nogueira, Ricardo C.
    Bor-Seng-Shu, Edson
    Saeed, Nazia P.
    Teixeira, Manoel J.
    Panerai, Ronney B.
    Robinson, Thompson G.
    [J]. FRONTIERS IN NEUROLOGY, 2016, 7
  • [40] Retrospective Analysis on Predictive Factors and Timeline for Early Neurologic Decline and Symptomatic Intracranial Hemorrhage Following Administration of Intravenous Recombinant Tissue Plasminogen Activator for Ischemic Stroke.
    Clark, Alexander
    Shah, Kavit
    Desai, Shashvat
    Jadhav, Ashutosh
    [J]. STROKE, 2021, 52
12345